ANDA 61639, held by Arbor Pharms LLC. Erythromycin Ethylsuccinate.
As of Nov 16, 2026, ANDA 61639 (E.E.S. 200, E.E.S. 400), held by Arbor Pharms LLC, was first approved by FDA on Oct 15, 1973, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 15, 1973 | Original application | Approved | None posted |
| E.E.S. 200EQ 200MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · suspension;oral | Erythromycin Ethylsuccinate | Discontinued |
| E.E.S. 400EQ 400MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · suspension;oral | Erythromycin Ethylsuccinate | Discontinued |
| Sep 1, 2015 | Supplement 33Labeling · Standard review | Approved | None posted |
| Oct 31, 2013 | Supplement 32Labeling · Standard review | Approved | |
| Feb 25, 2009 | Supplement 28Labeling | Approved | None posted |
| Feb 25, 2009 | Supplement 29Labeling | Approved | None posted |
| Jul 21, 2006 | Supplement 26Labeling | Approved | None posted |
| Jan 17, 2001 | Supplement 23Labeling | Approved | None posted |
| Nov 16, 2000 | Supplement 22Labeling | Approved | None posted |
| Nov 28, 1997 | Supplement 21Manufacturing | Approved | None posted |
| Sep 26, 1991 | Supplement 19Manufacturing | Approved | None posted |
| Oct 15, 1973 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters